Kevin F McLaughlin's Net Worth
$23.6 Million
Estimate Recalculated Nov 1, 2024 05:01AM EST
Who is Kevin F McLaughlin?
Kevin F McLaughlin has an estimated net worth of $23.6 Million. This is based on reported shares across multiple companies, which include Vericel Corp, Decibel Therapeutics, Inc., ACCELERON PHARMA INC, PRAECIS PHARMACEUTICALS INC, and Invivyd, Inc..
SEC CIK
Kevin F McLaughlin's CIK is 0001214938
Past Insider Trading and Trends
2015 was Kevin F McLaughlin's most active year for acquiring shares with 25 total transactions. Kevin F McLaughlin's most active month to acquire stocks was the month of November. 2015 was Kevin F McLaughlin's most active year for disposing of shares, totalling 59 transactions. Kevin F McLaughlin's most active month to dispose stocks was the month of November. 2020 saw Kevin F McLaughlin paying a total of $3,573,047.72 for 151,328 shares, this is the most they've acquired in one year. In 2020 Kevin F McLaughlin cashed out on 215,329 shares for a total of $11,450,947.89, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vericel Corp (VCEL) Snapshot price: $45.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$24.84 | -$295,400.00 | 11.9K |
Aug 7
| |||
Form 4
| +36.78% | 3.2K |
—
|
—
| 11.9K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +42.62% | 2.6K |
—
|
—
| 8.7K |
Apr 27
| |||
Form 4
| +74.29% | 2.6K |
—
|
—
| 6.1K |
Apr 27
| |||
Form 4
| +100.00% | 1.75K |
—
|
—
| 3.5K |
Apr 28
| |||
Form 4
|
∞
| 1.75K |
—
|
—
| 1.75K |
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Decibel Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.00K |
—
|
—
|
0
|
Sep 25
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACCELERON PHARMA INC No price found
SVP, CFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.68K |
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
$100.11 | -$3,011,252.40 | 10.68K |
Scheduled
|
Sep 23 - Sep 24
| ||
Form 4
| +83.74% | 4.87K |
—
|
—
| 10.68K |
Jan 29
| |||
Form 4
| -48.17% | -5.40K |
$123.37 | -$666,543.28 | 5.81K |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
|
—
|
0
|
$81.21 | -$4,161,435.00 | 11.22K |
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
$81.65 | -$648,127.36 | 11.22K |
Scheduled
|
Dec 9 - Dec 11
| ||
Form 4
|
—
|
0
|
$60.91 | -$2,749,934.86 | 11.22K |
Scheduled
|
Apr 8 - Apr 9
| ||
Form 4
| +131.40% | 6.37K |
—
|
—
| 11.22K |
Jan 22
| |||
Form 4
| -53.51% | -5.58K |
$52.50 | -$292,922.95 | 4.85K |
Scheduled
|
Jan 2
| ||
Form 4
| -53.20% | -11.85K |
$50.28 | -$595,968.84 | 10.43K |
Scheduled
|
Dec 13
| ||
Form 4
| -26.42% | -8.00K |
$45.30 | -$362,399.58 | 22.28K |
Scheduled
|
Sep 10
| ||
Form 4
| -28.38% | -12.00K |
$44.62 | -$535,405.00 | 30.28K |
Scheduled
|
Apr 9
| ||
Form 4
| -1.51% | -648.00 |
$48.02 | -$31,116.96 | 42.28K |
Scheduled
|
Apr 2
| ||
Form 4
| +12.29% | 4.7K |
—
|
—
| 42.93K |
Jan 25
| |||
Form 4
| -13.00% | -5.71K |
$42.80 | -$244,494.03 | 38.23K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$40.99 | -$325,375.00 | 43.94K |
Scheduled
|
Aug 30
| ||
Form 4
|
—
|
0
|
$36.06 | -$597,250.00 | 43.94K |
Scheduled
|
Jun 29
| ||
Form 4
| -8.34% | -4.00K |
$38.45 | -$153,792.00 | 43.94K |
Scheduled
|
Apr 3
| ||
Form 4
| +12.00% | 5.14K |
—
|
—
| 47.94K |
Mar 1
| |||
Form 4
| -13.18% | -6.50K |
$23.74 | -$757,594.12 | 42.8K |
Scheduled
|
Jan 2 - Jan 4
| ||
Form 4
| -24.50% | -16.00K |
$38.41 | -$614,546.30 | 49.3K |
Scheduled
|
Sep 12
| ||
Form 4
| -16.07% | -12.50K |
$19.43 | -$950,668.00 | 65.3K |
Scheduled
|
Jul 5
| ||
Form 4
| +9.73% | 6.9K |
—
|
—
| 77.8K |
Mar 2
| |||
Form 4
| -2.34% | -1.70K |
$27.45 | -$46,667.00 | 70.9K |
Scheduled
|
Jan 4
| ||
Form 4
| +15.97% | 10K |
$3.88 | $38,800.00 | 72.6K |
Jan 3
| |||
Form 4
| +8.68% | 5K |
$3.88 | $19,400.00 | 62.6K |
Jul 7
| |||
Form 4
| -14.79% | -10.00K |
$19.97 | -$796,114.00 | 57.6K |
Scheduled
|
Jul 1
| ||
Form 4
| -27.00% | -25.00K |
$19.64 | -$858,616.00 | 67.6K |
Scheduled
|
May 23
| ||
Form 4
| +5.83% | 5.1K |
—
|
—
| 92.6K |
Mar 3
| |||
Form 4
| +9.38% | 7.5K |
$3.88 | $29,100.00 | 87.5K |
Dec 22
| |||
Form 4
|
—
|
0
|
$14.13 | -$143,479.20 | 80K |
Scheduled
|
Oct 7
| ||
Form 4
| +100.00% | 40K |
—
|
—
| 80K |
Sep 9
| |||
Form 4
|
—
|
0
|
$17.02 | -$170,803.24 | 40K |
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$16.21 | -$160,212.00 | 40K |
Scheduled
|
Aug 10
| ||
Form 4
| +14.29% | 5K |
$3.88 | $19,400.00 | 40K |
Jul 28
| |||
Form 4
|
—
|
0
|
$16.79 | -$180,751.19 | 35K |
Scheduled
|
Jul 7
| ||
Form 4
| +16.67% | 5K |
$3.88 | $19,400.00 | 35K |
Jun 10
| |||
Form 4
|
—
|
0
|
$18.19 | -$185,951.00 | 30K |
Scheduled
|
Jun 8
| ||
Form 4
| +20.00% | 5K |
$17.84 | -$162,061.00 | 30K |
Scheduled
|
May 11
| ||
Form 4
|
—
|
0
|
$19.38 | -$217,005.00 | 25K |
Scheduled
|
Apr 7
| ||
Form 4
|
—
|
0
|
$22.07 | -$236,426.63 | 25K |
Scheduled
|
Mar 9
| ||
Form 4
|
—
|
0
|
$20.26 | -$212,959.00 | 25K |
Scheduled
|
Feb 9
| ||
Form 4
|
—
|
0
|
$22.27 | -$73,557.70 | 25K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
$21.67 | -$177,906.00 | 25K |
Scheduled
|
Jan 7 - Jan 8
| ||
Form 4
| +150.00% | 15K |
$3.88 | $58,200.00 | 25K |
Dec 19
| |||
Form 4
|
—
|
0
|
$23.95 | -$401,436.72 | 10K |
Scheduled
|
Dec 8
| ||
Form 4
|
—
|
0
|
$18.51 | -$292,622.22 | 10K |
Scheduled
|
Nov 12
| ||
Form 4
|
∞
| 10K |
$3.88 | $38,800.00 | 10K |
Oct 27
| |||
Form 4
|
—
|
0
|
$16.57 | -$253,700.00 |
0
|
Scheduled
|
Oct 7
| ||
Form 4
|
—
|
0
|
$14.18 | -$205,966.70 |
0
|
Scheduled
|
Sep 8 - Sep 9
| ||
Form 4
|
—
|
0
|
$16.83 | -$259,010.00 |
0
|
Scheduled
|
Aug 14
| ||
Form 4
|
—
|
0
|
$17.80 | -$278,374.00 |
0
|
Scheduled
|
Jul 7
| ||
Form 4
|
—
|
0
|
$17.77 | -$277,670.92 |
0
|
Scheduled
|
Jun 9
| ||
Form 4
|
—
|
0
|
$17.70 | -$276,343.48 |
0
|
Scheduled
|
May 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PRAECIS PHARMACEUTICALS INC No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -45.00K |
$5.00 | -$225,000.00 |
0
|
Feb 7 - Feb 8
| |||
Form 4
| +116.35% | 24.2K |
$1.33 | $32,186.00 | 45K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
| +10.64% | 10K |
$0.27 | $2,700.00 | 104K |
Feb 6
| |||
Form 4
| +2.17% | 2K |
$0.27 | $540.00 | 94K |
Dec 30
| |||
Form 4
| -4.37% | -10.00K |
$3.88 | -$255,254.60 | 219K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
| No matching records found | |||||||||
Invivyd, Inc. (IVVD) Snapshot price: $0.822
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||